BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9544880)

  • 1. Antihypertensive drug treatment and fibrinolytic function.
    Lottermoser K; Weisser B; Hertfelder HJ; Wöstmann B; Vetter H; Düsing R
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):378-84. PubMed ID: 9544880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?
    Fogari R; Zoppi A
    Am J Cardiovasc Drugs; 2005; 5(4):211-23. PubMed ID: 15984904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.
    Vaughan DE
    Eur Heart J; 1998 Jul; 19 Suppl G():G9-12. PubMed ID: 9717049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic function in diuretic-induced volume depletion.
    Lottermoser K; Hertfelder HJ; Vetter H; Düsing R
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):359-63. PubMed ID: 10821336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult hypertension: reducing cardiovascular morbidity and mortality.
    Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
    Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
    Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension: are beta-blockers and diuretics appropriate first-line therapies?
    Wilson MD; Weart CW
    Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.